4Damien Logear and Jean-Yves Tabet . Transient worsening of renal function during hospitalization for acute heart failure alters outcome[J]. International Journal of Cardiology, 2007,127(2) :228-232.
5McAlister FA, Ezekowitz J, Tonelli M, et al . Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study[J]. Circulation ,2004, 109(8) :1004-1009.
6Boerrigter G and Burnett JC. Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications[J]. Curr Heart Fail Rep ,2004,1(3) : 113-120.
7Heywood JT . The cardiorenal syndrome: lessons from the ADHERE database and treatment options[J]. Heart Fail Rev ,2004,9(3) : 195-201.
8McCullough PA and Sandberg KR. Sorting out the evidence on natriuretic peptides[J]. Rev Cardiovasc Med ,2003,4(4) : S13- S19.
9Roland RJ, van Kimmenade, James L, et al . Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure Redefining the Cardiorenal Interaction [ J ]? Journal of the American College of Cardiology , 2006,48(8) :1621- 1627.
10McCullough PA, Kuncheria J and Mathur VS. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure[J]. Rev Cardiovasc IVied ,2004,5(1) :16-25.
